DETERMINATION OF CHROMATOGRAPHIC ASSAY AND VALIDATION OF OFLOXACIN IN BULK AND PHARMACEUTICAL DOSAGE FORM

Sumithra M

doi:10.22159/ajpcr.2018.v11s4.31700

Authors

Sumithra M Department of Pharmaceutical Chemistry and Analysis, School of Pharmaceutical Sciences, Vels Institute of Science, Technology and Advanced Studies, Chennai, Tamil Nadu, India.

DOI:

https://doi.org/10.22159/ajpcr.2018.v11s4.31700

Keywords:

Reverse phase high performance liquid chromatography, Validation, Tablets, Ofloxacin

Abstract

Objective: The objective of the study is simple, sensitive; eco-friendly reverse phase chromatographic method has been developed and validated for the quantitative determination of ofloxacin in bulk and marketed formulation.

Method: The developed method was done using Hypersil silica C18 (250 mm Ã— 4.6 mm, 5 Î¼ particle size) as column and the mobile phase is containing water and methanol in the ratio of (10:90) vol/vol. The mobile phase pass at 1 ml/min flow rate and the eluted solution is measured at 270 nm using a PDA detector.

Results: The assay method is linear from the concentration range of 5â€“30 Î¼g/ml. The corelation coefficient is 0.9998. The mean percentage recovery for the developed method is found to be in the range of 98.4â€“100.6%. The developed method complies robustness studies.

Conclusion: The validation of the developed method was done by as per the ICH guidelines. It obeys the linearity, accuracy, precision, and robustness studies. Validation parameters are within the limitations. The results of the developed process indicated the reverse phase chromatographic method is simple, accurate as well as precise, rapid and eco-friendly method for routine analysis of ofloxacin in bulk and its pharmaceutical dosage form.

Downloads

Download data is not yet available.

References

The Internet Drug Index. Specialized Information Services. Available from: http://www.rxlist.com/floxin-drug/indications-dosage.htm. [Last cited on 2018 Jan 02].

Parfitt K. Martindale the Complete Drug Reference. London: The Pharmaceutical Press; 1999. p. 233-89.

Maryadele JO. Merck Index. Whitehouse Station, NJ: Merck and Co.; 2001. p. 9525.

Daharwal SJ, Swarnlata S, Saraf S. Spectrophotometric methods for estimation of ofloxacin and tinidazole from tablet dosage form. Indian Pharm 2008;7:73-9.

Kumar R, Singh P, Singh H. Development of colorimetric method for the analysis of pharmaceutical formulation containing both ofloxacin and cefixime. Int J Pharm Pharm Sci 2011;3:178-9.

Suslu N, Tamer A. Application of bromophenol blue and bromocresol purple for the extractive-spectrophotometric determination of ofloxacin. Anal Lett 2003;36:l1163-81.

Gandhimathi M, Ravi TK, Nilima S. Validated high performance thin layer chromatography method for simultaneous estimation of ofloxacin and ornidazole in tablet dosage form. Indian J Pharm Sci 2006;68:838-40.

Ohkubo T, Kudo M, Sugawara K. Determination of ofloxacin in human serum by high-performance liquid chromatography with column switching. J Chromatogr B: Biomed Sci Appl 1992;573:289-93.

Kamble NS, Venkaachalm A. High performance liquid chromatography determination of ornidazole and ofloxacin in solid dosage form. Indian Drugs 2005;42:723-5.

Khandagle KS, Gandhi SV, Deshpande PB, Gaikwad NV. A simple and sensitive RP-HPLC method for simultaneous estimation of cefixime and ofloxacin in combined tablet dosage form. Int J Pharm Sci 2011;3:46-8.

Sumithra M. Application of quality by design (CCD Technique) for simultaneous estimation of cefixime and ofloxacin by HPTLC method. Int J Pharm Pharm Sci 2016;8:200-8.

Validation of Analytical Procedure: Methodology Q2B, ICH Harmonized Triplicate Guidelines; 1996. p. 1-8.